Obagi Medical Products (OMPI) leap as Valeant buys
Obagi Medical Products, Inc (NASDAQ: OMPI) shares galloped 28% to $19.69, after it entered into a definitive merger agreement with Valeant Pharmaceuticals International, Inc. under which Valeant will acquire all of the outstanding common stock of Obagi for $19.75 per share in cash. Share volume was 10.6 million, triumphing over an all-day average of 87,000
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here